Long-Term Antibody Response and Vaccination Efficacy in Patients with COVID-19: A Single Center One-Year Prospective Study from the Czech Republic.

Viruses · 2022 · PMC8949942 · PMID 35336932

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

At the subsequent timepoints of 2 weeks and 3 months, the titers of 1:160 and higher were detected in 84.15% and 63.79% of patients in cohort A, respectively, where the increase in VNTs at the 2-weeks timepoint was highly significant ( Figure 4 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.